SMO-IN-2 is a potent and selective inhibitor of Smoothened (SMO), a key component in the Hedgehog (Hh) signaling pathway. It is primarily used in research settings to study the role of this pathway in cellular processes such as proliferation, differentiation, and tissue homeostasis. Due to the involvement of the Hedgehog pathway in certain cancers, SMO-IN-2 serves as a valuable tool compound in oncology research, particularly in models of basal cell carcinoma, medulloblastoma, and other tumors driven by aberrant Hh signaling. It helps in understanding mechanisms of drug resistance and pathway regulation, and is often used in combination studies with other targeted agents. Its application is mainly confined to in vitro and preclinical in vivo studies, supporting the development of new therapeutic strategies.